BRIEF-Endo Announces Initiation Of Clinical Trials Of Cellulite Treatment Drug
February 06, 2018 at 07:40 AM EST
* ENDO ANNOUNCES INITIATION OF TWO PIVOTAL PHASE 3 CLINICAL TRIALS OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM FOR THE TREATMENT OF CELLULITE Source text for Eikon: Further company coverage:
